EGFR and lung cancer: Monoclonal antibodies are aimed solely to target receptors such as the Epidermal Growth Factor Receptor, EpCAM receptor, NSE receptor, and other receptors that are abundantly expressed in lung cancer (Tseng et al., 2007; Wang & Zhou, 2015; Chen et al., 2021).